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Surfactant-like peptides are a class of amphiphilic macromolecules, which are able to self-assemble 17 
in water forming different supramolecular structures. Among them, octapeptides composed of six 18 
hydrophobic and two hydrophilic residues have attracted interest since they have a length similar to 19 
those of natural phospholipids. Supramolecular structures of different amphiphilic octapeptides have 20 
been widely reported, but no study has been performed aimed at investigating the effect of 21 
PEGylation on their self-assembling behaviour. The aim of the present work was to synthesize and 22 
characterise the self-assembling behaviour of PEGylated alanine- or valine based amphiphilic 23 
octapeptides (mPEG1.9kDa-DDAAAAAA and mPEG1.9kDa-DDVVVVVV) in comparison to the non-24 
PEGylated ones (DDAAAAAA and DDVVVVVV).  25 
The self-aggregation process in ultrapure water was investigated by fluorescence spectroscopy, small 26 
angle neutron scattering (SANS), dynamic light scattering (DLS), while the secondary structure was 27 
assessed by circular dichroism.  28 
PEGylation markedly affects the self-assembling behaviour of these amphiphilic octapeptides in 29 
terms of both critical aggregation concentration (CAC) and shape of the formed supramolecular 30 
aggregates. Indeed, PEGylation increases CAC and prevents the self-aggregation into fibrillary 31 
supramolecular aggregates (as observed for non-PEGylated peptides), by promoting the formation of 32 
micelle-like structures (as demonstrated for valine-based octapeptide).  33 
 2 
On the other side, the secondary structure of peptides seems not to be affected by PEGylation. Overall, 34 
these results suggest that self-assembling behaviour of amphiphilic octapeptides can be modified by 35 
PEGylation, with a great potential impact for the future applications of these nanomaterials. 36 
 37 
KEYWORDS: surfactant-like peptides, PEGylated peptides, nanostructures, small angle neutron 38 
scattering (SANS), micelles. 39 






























In recent years, molecular self-assembly of peptides has attracted great interest due to wide potential 69 
applications in nanotechnology and nanomedicine for the design of nanostructured smart materials 1. 70 
The amphiphilic self-assembled peptides are termed as “surfactant-like peptides”. They are composed 71 
of a sequence of consecutive hydrophobic amino acids as the tail and one or two hydrophilic amino 72 
acids as the head 2. Generally, the hydrophobic sequences contain glycine (G), alanine (A), valine 73 
(V), leucine (L) or isoleucine (I) residues, while the hydrophilic heads are made up of negatively (i.e. 74 
aspartic (D) or glutamic acid (E)) or positively (i.e. lysine (K), histidine (H) or arginine (R)) charged 75 
amino acids. The hydrophobic tail of a surfactant-like peptide is composed of six to nine hydrophobic 76 
residues, so that it is similar to the length of natural phospholipids (around 2.5-3 nm).  77 
Valine and alanine residues are preferred to glycine, leucine and isoleucine residues since they 78 
produce more homogeneous and stable structures, probably due to the formation of stronger β-sheet 79 
elements 3.  80 
The self-assembling properties of these materials can be tuned by changing the peptide sequences, 81 
both in the hydrophobic and hydrophilic region, giving a range of supramolecular architectures, 82 
including nanotubes, nanovesicles or nanofibers. Upon dissolution in water (4-5 mM), negatively 83 
charged peptides, such as Ac-A6D, Ac-V6D, Ac-G8DD or KV6, are able to form open-ended 84 
nanotubes with 30-50 nm of diameter and different lengths up to 1 µm 4.  85 
The amphiphilic sequences consisting of alanine, valine and glutamic acid can be coupled with other 86 
materials to produce nanostructures with a wide range of applications. In one such example, these 87 
sequences were coupled with a palmitoyl chain to form fibrillar nanostructures as promising 88 
biomimetic hydrogel scaffolds 5. In fact, Pashuck et al. observed that the arrangement of the 89 
hydrophobic residues not only affects the supramolecular structures but also the stiffness of the 90 
obtained hydrogel as a function of the total number of the hydrophobic residues and the strength of 91 
the β-sheet regions. The functionalization with lipids was also found to increase the in vivo stability 92 
of peptides. 93 
Apart from the modification with lipids, no other chemical functionalization of these alanine, valine 94 
or glutamic based amphiphilic peptides is reported in the literature.  95 
PEGylation is a common and well known strategy to improve water solubility and stability of 96 
peptides, and PEGylated peptides offer other advantages following in vivo administration, including 97 
increased plasma half-life and reduced immunogenity 6.  98 
Different studies were recently performed on a tetra-phenylalanine peptide linked to PEGs with 99 
different molecular weights (5 kDa, 1.8 kDa, 1.2 kDa and 350 Da) to investigate the self-assembling 100 
behaviour in aqueous solution 7–10. As an example, amphiphilic 3-helix PEGylated lipopeptides were 101 
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synthesized and were found to self-assemble into monodisperse micellar nanoparticles of 15 nm 102 
diameter. After loading with doxorubicin, used as model anticancer drug, they showed minimal 103 
leakage after 12 h of incubation with serum proteins at 37 °C. Moreover, the in vivo half-life was 104 
29.5 hours and minimal accumulation in the liver and spleen was observed using positron emission 105 
tomography 11.  106 
Despite the well-established beneficial attributes and improved performances imparted by 107 
PEGylation on different peptides, no study has been focused on the effect of PEGylation on the self-108 
assembling behaviour of surfactant-like octapeptides. Thus, the aim of this work was to synthesize 109 
and investigate for the first time the self-assembling behaviour in water of PEGylated alanine- and 110 
valine-based surfactant-like octapeptides (mPEG1.9kDa-DDAAAAAA and mPEG1.9kDa-111 
DDVVVVVV) and to compare them with the non-PEGylated ones (DDAAAAAA and 112 
DDVVVVVV).  113 
 114 
EXPERIMENTAL SECTION 115 
 116 
Synthesis of amphiphilic octapeptides 117 
 118 
All peptides were synthesized through the solid phase automated microwaved-assisted approach 119 
starting from protected amino acid Fmoc-ALA-OH (Fluorochem, UK), Fmoc-VAL-OH 120 
(Fluorochem, UK) Fmoc-ASP(otbu)-OH (Fluorochem, UK). Rink amide ChemMatrix (Biotage, NC, 121 
USA) was used as resin. For the amino acid sequence, the coupling agents were Ethyl 2-cyano-2 122 
(hydroxyimino) acetate (Oxyma; Fluorochem, UK) and N, N′-Diisopropylcarbodiimide (DIC; 123 
Fluorochem, UK). Coupling were performed at 75 °C for 5 minutes from the first to the fourth amino 124 
acid, for 7 minutes from the fifth and sixth amino acid and for 10 minutes for the last two amino 125 
acids. Subsequently, carboxylic-ended poly(ethylene glycol) monomethyl ether (1.9 kDa)  was 126 
coupled to the amino end of the amino acid sequence attached to the resin. Carboxylic-ended 127 
poly(ethylene glycol) monomethyl ether was synthesized from mPEG (1.9 kDa; Polysciences Europe, 128 
Germany). For the synthesis, mPEG was functionalised on the free hydroxyl group with glutaric 129 
anhydride (Sigma Aldrich, Italy), using 4-Dimethylaminopyridine (DMAP, Sigma Aldrich, Italy) as 130 
organocatalyst, in dichloromethane, to obtain a carboxylic end. After the reaction, the polymer was 131 
purified by dialysis using 1 kDa MWCO membrane (Spectra/Por®, USA). 132 
Carboxylic-ended poly(ethylene glycol) monomethyl ether was characterised by 1H-NMR and gel 133 
permeation chromatograpy (GPC) analysis (Mn 1842; Mw 2005; PDI 1,088). The Carboxylic-ended 134 
poly(ethylene glycol) monomethyl ether coupling was performed using 1-135 
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[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate 136 
(HATU, Sigma-Aldrich, UK) and N,N-Diisopropylethylamine (DIPEA; Sigma-Aldrich, UK) at 75 137 
°C for 10 minutes. After cleavage from the resin with trifluoroacetic acid (Fluorochem, UK), peptides 138 
were precipitated in cold diethyl ether. The raw materials were purified through RP-HPLC (Thermo 139 
Scientific Dionex Ultimate 3000 RP-HPLC equipped with a Phenomenex Gemini NX C18 110 Å, 140 
150 x 4.6 mm) column, using the following buffer systems: A: 50 mM ammonium carbonate, B: 141 
acetonitrile and a flow rate of 1 ml/min. The following gradient was applied: 95% A for 2 min; 5-142 
95% B in 25 min; 95% B for 5 min.  143 
 144 
Mass analysis 145 
For electron spray mass ionization (ESI) analysis, approximately 1 mg of each peptide was dissolved 146 
in ultrapure water and analysed by direct injection in an ESI mass apparatus (HP 1100 LC/MSD, 147 
Agilent) equipped with a single quadrupole detector. The sample was analysed in the positive mode 148 
at a fragmentor voltage of 30 V. 149 
MALDI-TOF spectra were acquired on a 400 Plus MALDI TOF/TOF Analyzer (AB Sciex, MA, 150 
USA). Peptides were dissolved in ultrapure water with 0.05% TFA and mixed, in the same volumetric 151 
amount, with the saturated matrix solution (2, 5-Dihydroxybenzoic acid saturated solution in 50:50, 152 
0.05% TFA water/acetonitrile). 1 μL of this solution was applied onto the MALDI sample plate and 153 
allowed to co-crystalize at room temperature and then analysed at a 6000 laser intensity.  154 
 155 
Circular Dichroism (CD) 156 
Far UV CD spectra of peptides were collected using a π*-180 step-flow spectrometer (Applied 157 
Photophysics, Leatherhead, UK). Peptides were analysed dissolved in ultrapure water at a 158 
concentration of 1 mg/mL for non-PEGylated and 3 mg/mL for PEGylated peptides. Spectra were 159 
recorded in the range of 180-280 nm with a step of 0.1 nm and a bandwidth of 1 nm. The acquisition 160 
time was 2 s for each point. A 10 mm path length quartz cuvette was filled with the peptide solution 161 
and measured at room temperature. 162 
 163 
Critical aggregation concentration (CAC)  164 
Steady-state fluorescence spectra of pyrene in the presence of different concentration of non-165 
PEGylated or PEGylated peptides were recorded at 37 °C using a spectrofluorimeter (LS-55, Perkin-166 
Elmer) equipped with a thermostated cell (HAAKE C25P thermostat). The fluorescence emission 167 
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spectra (350–600 nm) of pyrene were measured using an excitation wavelength λexc = 338 nm and 168 
2.5 nm slits. The intensity ratio of the first (I) and third (III) vibronic band of the emission spectrum 169 
of pyrene, at 372 nm and 384 nm, was plotted against the peptide concentration. The critical 170 
aggregation concentration (CAC) of peptides was determined by fitting the experimental data with 171 
the following equation (GraphPad Prism 6): 172 
𝑌 =
𝐵𝑜𝑡𝑡𝑜𝑚 + (𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚)
1 + 10^[(𝐿𝑜𝑔𝐶𝑀𝐶 − 𝑥) ∗ 𝐻𝑖𝑙𝑙 𝑠𝑙𝑜𝑝𝑒
 173 
where Top and Bottom are the plateau of the curve in the unit of Y axis, hill slope is the steepness of 174 
the curve.  175 
 176 
Small angle neutron scattering (SANS) 177 
SANS data were collected on the LOQ small-angle diffractometer at the ISIS Pulsed Neutron Source 178 
(STFC Rutherford Appleton Laboratory, Didcot, U.K.), using a two-dimensional, position-sensitive, 179 
3He detector neutron detector to provide a simultaneous Q range of 0.08−2 nm-1 12,13. Each sample 180 
and solvent (D2O for background) was placed in 2 mm path length quartz banjo cuvettes and measured 181 
for a total of 2 hours in order to gather data of high statistical precision. Each raw scattering data set 182 
was then corrected for the detector efficiencies, sample transmission and background scattering and 183 
converted to scattering cross-section data (∂Σ/∂Ω vs Q) using the instrument-specific software 184 
(MantidPlot) 14. Non-PEGylated peptides were analysed at 5 mg/mL, while PEGylated peptides at 30 185 
mg/mL in ultrapure water at 37 °C. The temperature was controlled by using a thermostat (Julabo 186 
bath) with a precision of 0.1 °C. SANS data were analysed using SASview 4.1 software. 187 
 188 
Dynamic light scattering (DLS)  189 
The hydrodynamic diameter (nm) and size distribution (width; nm) of non-PEGylated and PEGylated 190 
peptides were determined by DLS from the size by intensity (%) traces. DLS measurements were 191 
carried out using a Zetasizer Nano S (Malvern Instruments, UK) that employs a 173° backscatter 192 
detector. For the analysis, samples were loaded inside disposable cuvette and equilibrated 300 s at 193 
the operating temperature. The operating settings were position (mm): 4.65; attenuator: 11 and 194 




RESULTS AND DISCUSSION 198 
 199 
All synthesized peptides were characterized by mass analysis. Mass analysis is a standard technique 200 
employed for the identification and determination of the eventual presence of impurities in the 201 
sample. ESI mass spectra (positive mode) indicate the purity of non-PEGylated peptides. In mass 202 
spectra, only one molecular ion (m/z) and the relative adduct ions can be recognized. For 203 
DDAAAAAA the molecular ion is at 674.5 m/z, while for DDVVVVVV the molecular ion is at 842.8 204 
m/z (Figure 1). These mass values are comparable to those theoretically calculated for these peptide 205 
sequences.  206 
 207 
 208 
Figure 1 ESI mass spectra of non-PEGylated amphiphilic octapeptides: DDAAAAAA (A) and   209 
DDVVVVVV (B). 210 
 211 
Due to the higher molecular weight (above 1000 Da), no reliable results were obtained from ESI mass 212 
analysis of PEGylated peptides. Specifically, a large number of fragment ions below 1000 Da were 213 
observed, which were not unambiguous assigned to the sample. Therefore, PEGylated peptides were 214 
subsequently analysed by MALDI-TOF. A single molecular weight distribution can be observed in 215 
the analysed mass range 1-5 kDa for both PEGylated peptides, referring to the PEGylated adducts, as 216 
demonstrated from the calculated average molecular weights (2778 Da for mPEG1.9kDa-DDAAAAAA 217 




Figure 2 MALDI-TOF mass spectra of PEGylated amphiphilic octapeptides: mPEG1.9kDa-221 
DDAAAAAA (A) and mPEG1.9kDa-DDVVVVVV (B). 222 
 223 
 224 
The secondary structure in aqueous dispersion of peptides was investigated by circular dichroism. As 225 
for other valine and alanine based-peptides 15–17, this analysis confirmed that the amphiphilic peptides 226 
assume predominantly a beta-sheet conformation in water, as indicated by a minimum in ellipticity 227 
at around 220 nm. An appreciable fraction of random coil was only observed for the non-PEGylated 228 
valine peptide (DDVVVVVV) due to the presence of a minimum at around 190-200nm. Random coil 229 
fraction was negligible for the other peptides. Notably, PEGylation does not affect the secondary 230 
structure of peptides since PEGylated amphiphilic octapeptides (DDAAAAAA and DDVVVVVV) 231 
maintains the beta-sheet conformation as the non-PEGylated ones (Figure 3). 232 
 233 
Figure 3 CD spectra of alanine-based (DDAAAAAA and mPEG1.9 kDa-DDAAAAAA) peptides (A) 234 
and valine-based (DDVVVVVV and mPEG1.9 kDa-DDVVVVVV) peptides (B). 235 
 236 
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The critical aggregation concentration (CAC) values of the synthesized peptides were calculated by 237 
steady state fluorescence from the I/III peak ratio of pyrene, used as a probe. This ratio is particularly 238 
sensitive to the polarity of the microenvironment around the probe, which decreases at a peptide 239 
concentration at which the aggregation process begins. The calculated CAC values were 0.055 ± 240 
0.003 mg/mL (0.065 mM; R2 = 0.993) for DDVVVVVV; 0.906 ± 0.047 mg/mL (1.3 mM; R2 = 0.982) 241 
for DDAAAAAA; 1.638 ± 0.402 mg/mL (0.6 mM; R2 = 0.994) for mPEG1.9kDa-DDVVVVVV. No 242 
changes in the I/III fluorescence ratio were observed for mPEG1.9kDa-DDAAAAAA at the tested 243 
concentrations, suggesting no aggregation process. The results clearly indicated the effect of peptide 244 
sequence and PEG-coupling on CAC. Particularly, the lower CAC values for DDVVVVVV peptide 245 
in comparison to DDAAAAAA peptides are related to the higher hydrophobicity of valine residues. 246 
On the other hand, PEGylation has an opposite effect by inducing an increase in the self-aggregation 247 
concentration of the analysed peptides. The lower fluorescence intensity I/III ratio reached for 248 
concentrations of non-PEGylated peptides above CAC, in comparison to mPEG1.9 kDa-DDVVVVVV, 249 
indicates a more hydrophobic environment of the core compared to that of aggregates formed by the 250 
analysed PEGylated peptide (Figure 4). 251 
 252 
Figure 4 Variation of fluorescence intensity for the ratio between vibrionic peak I (λ 372 nm) and 253 
peak III (λ 384 nm) of pyrene as a function of concentration for non-PEGylated (DDAAAAAA and 254 
DDVVVVVV) and PEGylated (mPEG1.9kDa-DDAAAAAA and mPEG1.9kDa-DDVVVVVV) 255 
octapeptides. 256 
 257 
The fitting of SANS profiles related to the PEGylated peptides, using the ellipsoid model, revealed 258 
the formation in aqueous dispersion of micellar-type aggregates with an elongated shape. The 259 
calculated radii were 5.1 nm (polar) and 11.7 nm (equatorial) for mPEG1.9kDa-DDVVVVVV and 1.8 260 
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nm (polar) and 1.7 nm (equatorial) for mPEG1.9kDa-DDAAAAAA. This result highlighted a self-261 
assembling process only for the PEGylated valine-based peptide and not for the alanine-based peptide 262 
at the tested concentration, confirming the results obtained from fluorescence spectroscopy using 263 
pyrene as a probe. On the contrary, non-PEGylated peptides showed a different scattering profiles 264 
which can be attributed to fibrillary structures of larger dimensions. DDVVVVVV profiles can be 265 
fitted with a lamellar model with a thickness of 2.8 nm, while for DDAAAAAA the lamellar thickness 266 
was around 12.0 nm. The higher computed polydispersity for DDAAAAAA with respect to 267 
DDVVVVVV peptides indicates the formation of less homogeneous structures for alanine based-268 
peptides (Figure 5A). The mPEG1.9kDa-DDVVVVVV peptide was also analysed at different 269 
concentrations above CAC (30 mg/mL, 10 mg/mL and 3 mg/mL). The fitting of the relative SANS 270 
profiles confirmed that the elongated shape of micellar aggregates for PEGylated valine octapeptide 271 
is maintained at all concentrations analysed above CAC (Figure 5B). 272 
 273 
Figure 5 SANS profiles for non-PEGylated (DDAAAAAA and DDVVVVVV) octapeptides at a 274 
concentration of 5 mg/mL and for PEGylated (mPEG1.9kDa-DDAAAAAA and mPEG1.9kDa-275 
DDVVVVVV) octapeptides at a concentration of 30 mg/mL (A). SANS profiles for the mPEG1.9 kDa-276 
DDVVVVVV octapeptide at different concentrations above CAC (30 mg/mL, 10 mg/mL and 3 277 
mg/mL) (B). Lines represent the fitted signals. 278 
 279 
 280 
Figure 6 shows the size distribution traces (intensity %) relative to the analysed PEGylated or non-281 
PEGylated amphiphilic DDVVVVVV peptide. A smaller and monomodal particle size distribution 282 
was observed for the PEGylated peptide, with a calculated hydrodynamic diameter of 26.63 ± 0.41 283 
nm. This size value is comparable to that of spherical/elongated micelles and comparable with the 284 
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range of size (10-50 nm) reported for other PEGylated peptides 18,19. On the other hand, bimodal and 285 
larger distributions were found for the non-PEGylated alanine based-peptide. The bimodal 286 
appearance of DLS traces related to non-PEGylated amphiphilic peptides (DDVVVVVV) reflects the 287 
possible non-spherical shape of these samples. DLS analysis in fact suggests the presence of at least 288 
two dimensions, one significantly below 100 nm (approximately 35-40 nm) and another from 200 nm 289 
to more than 1000 nm. This result can be explained by considering DDVVVVVV could form 290 
fibrillary supramolecular structures, as reported in the literature for similar amphiphilic peptides 20,21.  291 
 292 
Figure 6 DLS traces of valine-based amphiphilic octapeptide at 25 °C before and after PEGylation 293 
obtained at a concentration above CAC (5 mg/mL for DDVVVVVV and 30 mg/mL for mPEG1.9kDa-294 
DDVVVVVV).  295 
 296 
Surfactant-like peptides represent a class of amphiphilic macromolecules, which have been widely 297 
characterized in terms of self-assembling behaviour. Amphiphilic peptides can form a number of 298 
supramolecular structures in water (e.g. nanofibers, nanorods, nanovesicles) due to different possible 299 
interactions between amino acid residues. Hydrogen bonds, van der Waals forces as well as 300 
electrostatic, hydrophobic and/or aromatic interactions (π–π stacking) can all be involved in the self-301 
assembling process. The properties of these peptides can be tuned by changing the amino acid 302 
sequence or by a further derivatization at the amino or carboxyl end groups, leading to the design of 303 
novel functional biomaterials. In the field of drug delivery, peptides have been largely investigated 304 
as potential macromolecules for the design of novel nanocarriers, since they display some advantages 305 
over common synthetic surfactants. These include a better biocompatibility and the possibility of 306 
inducing specific biological functions or controlling drug release and enhancing cell uptake in 307 
response to stimuli, based on the amino acid sequence.  308 
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The drawbacks of nanosystems formed by the self-assembly of surfactant-like peptides however 309 
include low stability in solution, poor aqueous solubility, potential heterogenicity of the 310 
nanoassemblies and the low drug loading. To overcome some limitations of these nanocarriers, 311 
hydrophilic peptides have been functionalized with fatty acids, to give rise to amphiphilic 312 
macromolecules, known as peptide amphiphiles, which, at the moment, represent the most 313 
investigated building blocks for the design of peptide-based nanocarriers.  314 
Additional functionalization strategies of peptides are possible, which maintain the amphiphilic 315 
character of these materials and the self-assembly ability. One of these is PEGylation. Covering the 316 
surface of nanosystems with PEG is, indeed, a very common strategy to reduce immunogenicity, 317 
thereby increasing the systemic circulation time. The use of PEGylated lipids to prepare PEGylated 318 
liposomes (the so-called second generation or stealth liposomes) is an established practice. 319 
PEGylation has also been demonstrated as an effective approach to improve the stability and 320 
solubility of peptides in water. Despite these advantages, not enough attention has been focused on 321 
the effect of PEGylation on the self-assembling behaviour.  322 
Self-assembling is known to be affected by the secondary structure (e.g. α-helix, β-sheets) and the 323 
obtained nanostructures (such as nanospheres, nanofibers, nanorods and nanotubes) are dependent on 324 
the feature of the hydrophilic and hydrophobic portions of the material 22. Different works have 325 
investigated the secondary structure of octapeptides 23,24. Particularly for surfactant-like peptides 326 
formed by six hydrophobic and one or two anionic residues, a β-sheet conformation has been reported 327 
21, which is probably related to the repetition of the hydrophobic residues such as alanine or valine, 328 
owing to the stacking interaction via intermolecular hydrogen bonds 3,25. In this work, a β-sheet 329 
conformation was observed for DDAAAAAA and DDVVVVVV peptides, which was not affected 330 
after conjugation with PEG. Actually, the effect of PEGylation on conformational stability of proteins 331 
or peptides is not well clarified 26. In some studies, no effect was observed on the secondary structure 332 
of epta- or octapeptides after PEGylation 27. No systematic studies can also be found in the literature 333 
in which CAC of PEGylated peptides are compared with that of non-PEGylated counterparts. 334 
Theoretically, PEGylation should increase the CAC value of peptides by increasing its hydrophilicity. 335 
For instance, CAC values in the range of µM up to 1-2 mM have been calculated for surfactant-like 336 
peptides 28–30, and, generally, higher CAC values (in the range of mM) have been found for PEGylated 337 
peptides 31,11. SANS profiles confirmed the effect exerted by the coupling of 1.9kDa PEG to the 338 
hydrophilic portion on the self-assembling behaviour of the investigated surfactant-like octapeptides. 339 
We demonstrate that, PEGylation maintains the self-assembling properties only for the valine-based 340 
octapeptide. This is different to the effect seen with alanine-based peptides, suggesting that the 341 
coupling with 1.9kDa PEG confers a high level of hydrophilicity, which can be balanced only by the 342 
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higher hydrophobicity of valine compared to alanine residues. Moreover, PEGylation seems to induce 343 
the formation of more homogeneous and elongated micelles, unlike non-PEGylated octapeptides for 344 
which fibrillar or ribbon-like structures have been already reported 32–34.  345 
 346 
CONCLUSIONS 347 
Overall, the results suggest that the PEGylation of amphiphilic alanine- or valine-based octapeptides 348 
markedly affects their self-assembling behaviour in terms of critical aggregation concentration as 349 
well as in terms of shape and structure of the formed supramolecular aggregates. Particularly, 350 
PEGylation increases the CAC of these amphiphilic peptides and prevents the self-aggregation into 351 
fibrillary aggregates. As evidenced by SANS and DLS, PEGylation promotes the formation of 352 
elongated micellar structure for valine-based amphiphilic octapeptides, differently from the alanine-353 
based amphiphilic octapeptide, which does not self-assemble at the concentrations tested (up to 30 354 
mg/mL). Conversely, PEGylation does not influence the secondary conformation of amphiphilic 355 
octapeptides as evidenced by circular dichroism. Overall, these results suggest that PEGylation can 356 
modify the self-assembling behaviour of amphiphilic octapeptides, leading to the formation of 357 
different supramolecular aggregates. These findings can be helpful to enlarge the future applications 358 
of these nanomaterials in different fields. 359 
 360 
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